Celon Pharma S.A. (CLN.WA)

PLN 25.35

(0.2%)

Total Liabilities Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual total liabilities in 2023 was 123.75 Million PLN , down -4.28% from previous year.
Celon Pharma S.A.'s latest quarterly total liabilities in 2024 Q2 was 116.95 Million PLN , up 15.96% from previous quarter.
Celon Pharma S.A. reported annual total liabilities of 129.28 Million PLN in 2022, down -15.57% from previous year.
Celon Pharma S.A. reported annual total liabilities of 153.13 Million PLN in 2021, down -43.07% from previous year.
Celon Pharma S.A. reported quarterly total liabilities of 100.86 Million PLN for 2024 Q1, down -18.5% from previous quarter.
Celon Pharma S.A. reported quarterly total liabilities of 114.87 Million PLN for 2023 Q3, down -7.91% from previous quarter.

Annual Total Liabilities Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Total Liabilities of Celon Pharma S.A. (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	123.75 Million PLN	-4.28%
2022	129.28 Million PLN	-15.57%
2021	153.13 Million PLN	-43.07%
2020	268.97 Million PLN	83.84%
2019	146.3 Million PLN	27.29%
2018	114.93 Million PLN	34.9%
2017	85.2 Million PLN	37.82%
2016	61.81 Million PLN	-8.38%
2015	67.47 Million PLN	88.38%
2014	35.81 Million PLN	17.86%
2013	30.38 Million PLN	113.63%
2012	14.22 Million PLN	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	116.95 Million PLN	15.96%
2024 Q1	100.86 Million PLN	-18.5%
2023 Q3	114.87 Million PLN	-7.91%
2023 Q1	149.81 Million PLN	15.87%
2023 Q4	123.75 Million PLN	7.72%
2023 FY	123.75 Million PLN	-4.28%
2023 Q2	124.75 Million PLN	-16.73%
2022 Q2	162.71 Million PLN	11.95%
2022 FY	129.28 Million PLN	-15.57%
2022 Q4	129.28 Million PLN	-13.42%
2022 Q1	145.34 Million PLN	-5.09%
2022 Q3	149.32 Million PLN	-8.23%
2021 Q2	171.22 Million PLN	-9.43%
2021 Q4	153.13 Million PLN	2.43%
2021 Q3	149.49 Million PLN	-12.69%
2021 Q1	189.04 Million PLN	-29.72%
2021 FY	153.13 Million PLN	-43.07%
2020 FY	268.97 Million PLN	83.84%
2020 Q4	268.97 Million PLN	15.14%
2020 Q3	233.6 Million PLN	10.26%
2020 Q2	211.87 Million PLN	46.21%
2020 Q1	144.9 Million PLN	-0.95%
2019 Q1	132.03 Million PLN	14.87%
2019 FY	146.3 Million PLN	27.29%
2019 Q4	146.3 Million PLN	7.11%
2019 Q3	136.58 Million PLN	-3.99%
2019 Q2	142.25 Million PLN	7.75%
2018 FY	114.93 Million PLN	34.9%
2018 Q2	103.21 Million PLN	17.95%
2018 Q3	99.58 Million PLN	-3.52%
2018 Q1	87.51 Million PLN	2.71%
2018 Q4	114.93 Million PLN	15.42%
2017 Q1	64.53 Million PLN	4.4%
2017 Q2	65.12 Million PLN	0.91%
2017 Q3	68.29 Million PLN	4.86%
2017 Q4	85.2 Million PLN	24.76%
2017 FY	85.2 Million PLN	37.82%
2016 FY	61.81 Million PLN	-8.38%
2016 Q4	61.81 Million PLN	-6.71%
2016 Q1	- PLN	-100.0%
2016 Q3	66.26 Million PLN	0.0%
2015 Q4	67.47 Million PLN	0.0%
2015 FY	67.47 Million PLN	88.38%
2014 FY	35.81 Million PLN	17.86%
2013 FY	30.38 Million PLN	113.63%
2012 FY	14.22 Million PLN	0.0%

Peer Total Liabilities Comparison of Celon Pharma S.A.

Name	Total Liabilities	Total Liabilities Difference